GSE132961
RNA-seq to identify targets of integrin alpha2 in breast cancer
Knockdown of ITGA2 was done in MDA-MB-231 cells and RNA-seq results were compared to control cells. Overall design: RNA-seq analysis were done in triplicates of knockdown control and ITGA2 knockdown. Submitted by: Nuseq Core facility of Northwestern